Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Managing lung cancer in the time of COVID-19

By

Estimated Read Time:

1 minute

Meeting News

Register Now
REGISTER NOW for the Medscape Education and IASLC Exclusive Webinar: Immunotherapy and the COVID-19 Pandemic: Addressing Clinical Case Challenges in Lung Cancer on Tuesday, August 11, 2020 @ 8:00 am EDT. This webinar will discuss the key issues regarding the use of immunotherapy today, including how and when to start and stop therapy, how to select a regimen, and how to approach the management of patients with lung cancer and COVID-19. This episode features Dr. Enriqueta Felip from the University Hospital Vall D’Hebron in Spain, Dr. Natasha B. Leighl from the University of Toronto and Dr. Tony S.K. Mok from the Chinese University of Hong Kong.

Moderator: IASLC Board of Directors member Clarissa Mathias, MD, Nucleo de Oncologia da Bahia, Brazil

Questions will be taken in advance that the panelists can answer during the session. If you have any questions related to this topic, please submit them by August 20 to: [email protected].


About the Authors